Navigation Links
The Journal of Allergy and Clinical Immunology devotes special issue to AIDS
Date:7/31/2008

Philadelphia 31 July 2008 The editors of The Journal of Allergy and Clinical Immunology are pleased to announce the July issue, highlighting AIDS and AIDS research. The Journal of Allergy and Clinical Immunology (http://www.jacionline.org/) is the official journal of the American Academy of Allergy and Clinical Immunology, and is published by Elsevier.

The issue coincides with the XVII International AIDS Conference, taking place at Centro Banamex, Mexico City, August 3 to 8, 2008. Donald M. Leung, Editor-in-Chief said, "AIDS is a topic of global importance and we believe that this collection of articles, written by some of the leading figures in HIV and AIDS research, will be of great interest to the many researchers and clinicians gathering in Mexico City."

Key papers include a review article by Barton F. Haynes from Duke University and Robin J. Shattock from St. George's University of London that summarizes some of the hurdles that researchers face in developing an HIV vaccine. Additionally, a mechanistic review by Susan Moir and Anthony S. Fauci from the National Institutes of Health's National Institute of Allergy and Infectious Diseases looks specifically at B-cell abnormalities associated with HIV, in the hopes that as the authors state in their article "A better understanding of the pathogenic mechanisms of B-cell abnormalities [] can potentially lead to new strategies for improving antibody responses."

Also, a Rostrum article by Lin Shen and Robert F. Siliciano from Johns Hopkins University argues that highly active antiretroviral therapy (HAART) must be combined with new techniques to attack the viral reservoirs that remain even after viral replication has been stopped.

Other issue highlights include original research from a National Institutes of Health multi-center group that finds an increased rate of asthma in HIV-infected children who are being treated with HAART; the report of genetic variations in the innate immune mannose lectin-binding pathway that changes the rate of HIV disease progression; and the laboratory advancement of measuring nave and late activated cytotoxic T lymphocytes as a simpler method of measuring thymic function.

Subscribers can access the full content of each issue of The Journal of Allergy and Clinical Immunology at the journal web site, www.jacionline.org. Institutional subscribers can access the journal through ScienceDirect, http://www.sciencedirect.com/science/journal/00916749.

Visitors to the XVII International AIDS Conference in Mexico City are encouraged to stop by the Elsevier display (Booth #503) to see the special AIDS issue and to learn how to subscribe to The Journal of Allergy and Clinical Immunology subscriber.


'/>"/>

Contact: Caroline Foote
c.foote@elsevier.com
215-239-3653
Elsevier
Source:Eurekalert

Related medicine news :

1. Alzheimers & Dementia: The Journal of the Alzheimers Association accepted for coverage in MEDLINE
2. 5.634 -- the new impact factor of European Urology underlines the journals outstanding position
3. Chicago-Based Speaker/Author Concurs with Research Finding of Using Journaling as a Tool to Combat Obesity and Other Health Problems
4. Human Factors Journal celebrates 50 years
5. Global Access Project (GAP) Study Examining Patients Access to Cancer Care Featured in the Journal of the American Medical Association (JAMA)
6. Mitigating Medical Identity Theft: AHIMA Journal Provides Patient Tools to Secure Health Information
7. American Heart Association Announces Fourth New Journal - Circulation: Cardiovascular Interventions to Debut in August
8. Elsevier announces 2007 journal impact factor highlights
9. Journal STEM CELLS Presents 3rd Annual Young Investigator Award at International Stem Cell Symposium
10. Dermatology Nurses Association Teams with International Publisher to Launch its Own Journal
11. Long-term safety data on Lialda published in leading GI journal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... Phytocéane ... Indian Ocean, isolated from the rest of the world with ZANZIBAR SHOWER GEL. Inspired ... Phytocéane used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral to create this ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... ... by Austin, Texas Periodontist Dr. Dan Holtzclaw in media for its creos™ line ... two surgeries performed by Dr. Holtzclaw in which he utilizes creos™ allo.gain™ bone ...
(Date:1/20/2017)... ... 2017 , ... Doctor C LLC, a company based out of Arizona that ... continue the marketing and distribution of its product, The Right C. , The Right ... absorption than traditional vitamin C supplements. At the trade show, Doctor C had the ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated 5 years ... Betsy, the clinical trial has been life-saving as she has been on the ... Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Code Word: Chocolate Biscuit”: a biographical account following a man who ... the creation of published author, Marlyn Ivey, born in Lynn Haven, Florida and at the ... and at 19 years of age, he joined the Navy and got married right out ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... RATON, Fla. , Jan. 19, 2017 /PRNewswire/ ... a medical device company specializing in the treatment ... such as keloids, with superficial radiation therapy, today ... and full year 2016 financial results on Thursday, February ... The Company will hold a conference call with ...
(Date:1/19/2017)... ALTO, Calif. , Jan. 19, 2017   ... research, is excited to announce that the first ... Cancer Biology  (RP:CB) have been published in eLife ... this project represents the first practical evaluation of ... result in reproducible studies. Unlike other assessments of ...
(Date:1/19/2017)... , January 19, 2017 ... appears serious about reducing the FDA,s regulatory strictness ... in the medical drug industry, many of the ... new clinical trials and development of advanced drug ... ahead with recent developments include:  Moleculin Biotech, Inc., ...
Breaking Medicine Technology: